UNSPSC 85445709: The diagnosis of antivaricose drugs, including sclerosing agents

In this classification, this covers the group of activities that yields a diagnosis of antivaricose drugs, including sclerosing agents. Antivaricose drugs, including sclerosing agents is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems (ICD-10) as a four-character category under code Y52.8.

UNSPSC 85445709 The diagnosis of antivaricose drugs, including sclerosing agents is a Commodity code with minimal recent activity under state and local procurement. The three most recent opportunities posted under this code show a substantial mismatch between the code's nominal scope—pharmaceutical diagnostics and sclerosing agents—and the actual work being solicited: San Mateo Medical Center's Diagnostic Imaging PACS system procurement, Birdville Independent School District's special education contracted services, and Santa Clara Health System's temporary health professional staffing. None of these solicitations involve antivaricose drugs or sclerosing agents. The code shows little relevant recent activity; the opportunities tagged to it appear to reflect miscoding rather than genuine demand for the pharmaceutical and diagnostic products the code name describes.

State and local procurement offices in California and Texas have posted the three identified opportunities, but none directly aligns with the code's intended scope. San Mateo County's October 21, 2026 RFP for diagnostic imaging PACS implementation involves medical imaging software and systems integration, not pharmaceutical diagnostics. Birdville Independent School District's October 21, 2026 RFQ for special education contracted services covers clinical and therapeutic personnel (audiologists, diagnosticians, therapists, counselors) across 30 school campuses. Santa Clara County Health System's October 7, 2026 qualification-based RFQ for temporary health professional staffing covers ancillary clinical positions including audiology, diagnostic imaging, and sterile processing, but excludes nursing and physician staffing. Absent coded opportunities that actually procure antivaricose drugs or sclerosing agents, this code does not present a current market signal for business development focus.